Creatine as a Therapeutic Target in Alzheimer's Disease

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, affecting approximately 6.5 million older adults in the United States. Development of AD treatment has primarily centered on developing pharmaceuticals that target amyloid-β (Aβ) plaques in the brain, a hallmark pathologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Aaron N., Morris, Jill K., Carbuhn, Aaron F., Herda, Trent J., Keller, Jessica E., Sullivan, Debra K., Taylor, Matthew K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Nutrition 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594571/
https://www.ncbi.nlm.nih.gov/pubmed/37881206
http://dx.doi.org/10.1016/j.cdnut.2023.102011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594571/
https://www.ncbi.nlm.nih.gov/pubmed/37881206
http://dx.doi.org/10.1016/j.cdnut.2023.102011

Ejemplares similares